Nektar Therapeutics Newsroom

Insider Sale: Chief Legal Officer of $NKTR (NKTR) Sells 33,402 Shares

Quiver QuantitativeDec 26 19:15 ET

Don't Ignore The Insider Selling In Nektar Therapeutics

Simply Wall StDec 22 08:13 ET

Promising Future for Nektar Therapeutics: Innovative Approach in Autoimmune Disease Treatment With Rezpegaldesleukin

TipRanksDec 12 02:45 ET

Express News | Nektar Therapeutics : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $6.5

ReutersDec 10 06:06 ET

Nektar Therapeutics Announced NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients With Relapsed or Refractory Large B-cell Lymphoma At ASH Meeting; 73% Of NKTR-255 Treatment Group Vs 50% Of Placebo Group...

BenzingaDec 7 15:28 ET

Express News | Nektar Therapeutics Announces Nktr-255 Following Cd19-Directed CAR-T Therapy Enhanced Complete Response Rates in Patients With Relapsed or Refractory Large B-Cell Lymphoma at the 66TH Annual Ash Meeting

ReutersDec 7 12:00 ET

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients With Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

NektarDec 7 00:00 ET

Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

PR NewswireDec 2 09:30 ET

B-cell Lymphoma Pipeline Insight 2024, With Comprehensive Insights for 295+ Companies and 300+ Pipeline Drugs - ResearchAndMarkets.com

BusinesswireNov 22 12:14 ET

Insider Sale: Chief R&D Officer of $NKTR (NKTR) Sells 7,785 Shares

Quiver QuantitativeNov 20 20:45 ET

Nektar Therapeutics Presents First Preclinical Data From Novel CSF-1 Program, NKTR-422, At 2024 American College Of Rheumatology Convergence; NKTR-422 Demonstrated Inflammation Resolution And Tissue Repair In Multiple Preclinical Models Of Chronic...

BenzingaNov 18 15:32 ET

Getting In Cheap On Nektar Therapeutics (NASDAQ:NKTR) Is Unlikely

Simply Wall StNov 18 10:10 ET

Nektar Therapeutics Presents First Preclinical Data From Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

NektarNov 18 00:00 ET

Nektar Therapeutics To Present At UBS Global Healthcare Conference; Webcast At 1:15 PM ET

RTTNewsNov 13 12:18 ET

Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Hold Rating

Moomoo NewsNov 12 08:31 ET · Ratings

Oppenheimer Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)

TipRanksNov 12 07:48 ET · Ratings

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets

Yahoo FinanceNov 10 09:43 ET

Nektar Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 8 12:20 ET · Announcements

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 8 00:34 ET · Conference Call

Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SECNov 7 16:39 ET